Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

News Conference News EuroPCR 2015

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Caitlin E. Cox

May 20, 2015

News Daily News

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

Todd Neale

November 17, 2014

Presentation TCT 2014

Comparison of Novel Zotarolimus-Eluting Cobalt-Chromium Stents and Everolimus-Eluting Platinum-Chromium Stents in Patients of the Randomized DUTCH PEERS Trial Presenting with___

Presenter: Marije L?wik

September 16, 2014

Presentation TCT 2014

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Presenter: Krishnankutty Sudhir

September 16, 2014

Presentation TCT 2014

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Presenter: Georgios Vlachojannis

September 16, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

Yael L. Maxwell

June 03, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

Advertisement

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

COMPARE: EES Maintains Advantage Over PES at 5 Years

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

Comparison of Novel Zotarolimus-Eluting Cobalt-Chromium Stents and Everolimus-Eluting Platinum-Chromium Stents in Patients of the Randomized DUTCH PEERS Trial Presenting with___

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing primary percutaneous coronary intervention: 5 year follow-up from the COMPARE I___

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content